Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Intangibles (2020 - 2025)

Maravai Lifesciences Holdings has reported Intangibles over the past 6 years, most recently at $151.5 million for Q4 2025.

  • Quarterly results put Intangibles at $151.5 million for Q4 2025, down 22.27% from a year ago — trailing twelve months through Dec 2025 was $151.5 million (down 22.27% YoY), and the annual figure for FY2025 was $151.5 million, down 22.27%.
  • Intangibles for Q4 2025 was $151.5 million at Maravai Lifesciences Holdings, down from $185.9 million in the prior quarter.
  • Over the last five years, Intangibles for MRVI hit a ceiling of $241.6 million in Q1 2023 and a floor of $117.6 million in Q4 2021.
  • Median Intangibles over the past 5 years was $204.6 million (2024), compared with a mean of $195.7 million.
  • Peak annual rise in Intangibles hit 5852.28% in 2021, while the deepest fall reached 33.82% in 2021.
  • Maravai Lifesciences Holdings' Intangibles stood at $117.6 million in 2021, then soared by 84.28% to $216.7 million in 2022, then increased by 2.0% to $221.0 million in 2023, then decreased by 11.78% to $195.0 million in 2024, then decreased by 22.27% to $151.5 million in 2025.
  • The last three reported values for Intangibles were $151.5 million (Q4 2025), $185.9 million (Q3 2025), and $193.1 million (Q2 2025) per Business Quant data.